Momenta Pharmaceuticals, Inc. (MNTA)

[Double_Bagel]

Momenta Pharma sues Amphastar for patent infringement

Momenta Pharmaceuticals announced that it has sued Amphastar Pharmaceuticals, Watson Pharmaceuticals, and International Medical Systems, in the United States District Court for the District of Massachusetts for infringement of two Momenta patents. The patents cover the company's innovative methods of producing enoxaparin sodium, which assure that the commercial product meets standards for identity and quality. One patent, U.S. Patent No. 7,790,466, is related to methods of processing enoxaparin to determine the presence of certain tetrasaccharide structures. The second patent, U.S. Patent No. 7,575,886, is related to methods of analyzing enoxaparin for the presence of a certain st ructural signature.

Fly on the Wall